Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

387 public trials 106 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors

NCT00137774

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Insitute Boston, Massachusetts, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Phase I Study of the Safety, Distribution, and Radiation Dosimetry of Ultratrace Iobenguane 123I-mIBG

NCT01730417

Conditions: Cardiovascular Diseases, Heart Diseases, Heart Failure, +6 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization

NCT00434109

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +22 more
Locations: H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

View Trial Details

Completed

89Zr-bevacizumab PET Imaging in Patients With Neuroendocrine Tumors

NCT01338090

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: University Medical Center Groningen Groningen, Netherlands

View Trial Details

Completed

ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid

NCT00339131

Conditions: Adenocarcinoma, Carcinoid, Carcinoid Tumor, +10 more
Locations: Not specified

View Trial Details

Completed

Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine Tumors

NCT00590343

Conditions: Metastatic Neuroendocrine Tumors, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations: Neuroendocrine Clinic Kenner, Louisiana, United States

View Trial Details

Completed

Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma

NCT00780663

Conditions: Adenocarcinoma, Carcinoid Tumor, Carcinoma, +7 more
Locations: Birmingham Hematology and Oncology Birmingham, Alabama, United States

Rocky Mountain Cancer Centers Denver, Colorado, United States

Front Range Cancer Specialists Fort Collins, Colorado, United States

Ocala, Florida, United States

View all 13 locations

View Trial Details

Completed

Gastrointestinal Motility in Patients With Neuroendocrine Tumors

NCT00789841

Conditions: Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms, +7 more
Locations: Analfysiologisk afsnit, Aarhus University Hospital, Tage Hansensgade, entrance 11A Aarhus, Denmark

View Trial Details

Completed

Pemetrexed in Patients With Advanced Neuroendocrine Tumors

NCT00424723

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Dana-Farber Cancer Center Boston, Massachusetts, United States

View Trial Details

Completed

High Dose Somatostatin Analogues in Neuroendocrine Tumors

NCT00990535

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, +24 more
Locations: University Federico II of Naples Naples, Italy

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions